The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.

Yildiz, RamazanBuyukberber, SuleymanKoca, DoganKorai, LokmanCiltas, AydinUnal, Olcun UmitGumus, Mahmut2024-02-232024-02-2320130732-183X1527-7755https://hdl.handle.net/20.500.12452/1730749th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2013 -- Chicago, IL[Abstract Not Availabe]eninfo:eu-repo/semantics/closedAccess[Keyword Not Available]The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.Conference Object3115Q1WOS:000335419603655Q1